These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22176685)

  • 1. Progranulin stimulated by LPA promotes the migration of aggressive breast cancer cells.
    Swamydas M; Nguyen D; Allen LD; Eddy J; Dréau D
    Cell Commun Adhes; 2011 Dec; 18(6):119-30. PubMed ID: 22176685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
    Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
    PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling.
    Du J; Sun C; Hu Z; Yang Y; Zhu Y; Zheng D; Gu L; Lu X
    PLoS One; 2010 Dec; 5(12):e15940. PubMed ID: 21209852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progranulin (PGRN) promotes invasion and migration of mouse breast cancer 4T1 cells by promoting epithelial-mesenchymal transition of cancer cells and activating ERK1/2 pathway].
    Fang W; Yue S; Gan D; Zhang D; Shi H; Yao M; Qian H; Zhou T; Chen T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Feb; 37(2):125-131. PubMed ID: 33504418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival.
    He Z; Ismail A; Kriazhev L; Sadvakassova G; Bateman A
    Cancer Res; 2002 Oct; 62(19):5590-6. PubMed ID: 12359772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation.
    Tang ZN; Zhang F; Tang P; Qi XW; Jiang J
    Oncol Rep; 2011 Nov; 26(5):1243-50. PubMed ID: 21725611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
    Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
    Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways.
    Lian X; Jiao Y; Yang Y; Wang Z; Xuan Q; Liu H; Lu S; Wang Z; Liu Y; Li S; Yang Y; Guo L; Zhao L; Zhang Q
    Med Oncol; 2015 Jan; 32(1):411. PubMed ID: 25476480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
    Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
    Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis.
    Li J; Jia L; Zhao P; Jiang Y; Zhong S; Chen D
    J Int Med Res; 2012; 40(2):545-55. PubMed ID: 22613415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration.
    Guha R; Yue B; Dong J; Banerjee A; Serrero G
    Breast Cancer Res Treat; 2021 Apr; 186(3):637-653. PubMed ID: 33616772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
    Normanno N; De Luca A; Maiello MR; Campiglio M; Napolitano M; Mancino M; Carotenuto A; Viglietto G; Menard S
    J Cell Physiol; 2006 May; 207(2):420-7. PubMed ID: 16419029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.
    Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S
    Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VI-14, a novel flavonoid derivative, inhibits migration and invasion of human breast cancer cells.
    Li F; Li C; Zhang H; Lu Z; Li Z; You Q; Lu N; Guo Q
    Toxicol Appl Pharmacol; 2012 Jun; 261(2):217-26. PubMed ID: 22538171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
    Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
    Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
    Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.